Drugs in Finland: occurrence and costs
Poikolainen, K.
Duodecim; Laaketieteellinen Aikakauskirja 114(20): 2103-2108
1998
ISSN/ISBN: 0012-7183 PMID: 11717736 Document Number: 494088
Document emailed within 1 workday
Related Documents
Estola, T.; Saikku, P.; Pirkola, M.; Häkkinen, I.; Veijalainen, P.; Ek-Kommonen, C. 1980: Occurrence of influenza a viruses and their antibodies in migratory birds in Finland Nordisk Veterinaermedicin 32(7-8): 321-324Pohjankoski, H.; Latva, K.; Kautiainen, H.; Säilä, H.; Klaukka, T.; Virta, L.; Puolakka, K.; Pohjolainen, T.; Savolainen, A. 2011: First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland Clinical and Experimental Rheumatology 29(5): 878-881
1999: Treatment of drug dependence in Finland. November 1-3, 1999, Espoo, Finland Duodecim; laaketieteellinen aikakauskirja 115(22): 2510-2522
Frisk, M.; Strömstedt, A. 2000: Choice of drugs--by whom, for whom and to what costs? Lakartidningen 97(39): 4343-4346
Rise, L. 2003: The costs of drugs against ADDH should be reduced Lakartidningen 100(26-27): 2316;AuthorReply 2316
Anttila, V.-J. 2003: New antifungal drugs--more efficacy or more costs? Duodecim; Laaketieteellinen Aikakauskirja 119(14): 1297-1299
Albert, H.; Busch, J.; Klier, B.; Klötzel, M.; Kühn, M.; Steinhoff, B. 2013: The occurrence of bromide in herbal drugs: is there a need for a Ph. Eur. limit? Pharmeuropa Bio and Scientific Notes 2013: 40-63
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Moon, S.; Van Leemput, L.; Durier, N.; Jambert, E.; Dahmane, A.; Jie, Y.; Wu, G.; Philips, M.; Hu, Y.; Saranchuk, P. 2008: Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough? Aids Care 20(8): 984-994
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
Jaramilla, J.P.; Colombo, J.; Simon, L. 1994: What strategies can be tried to keep costs of antibiotics and other high-priced drugs from becoming true budget busters? Hospital Formulary 29(4): 305-308
Jensen, O.H.; Danneskiold-Samsøe, B. 1985: Costs of drugs in connection with rheumatoid arthritis. Consequences of the new Danish cuts in subsidies Ugeskrift for Laeger 147(19): 1570-1572
Mèszàros, J. 1983: Adverse effects of drugs: mechanisms and factors affecting their occurrence Polski Tygodnik Lekarski 38(51-52): 1615-1620
Greczyn, R.J. 2003: Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference North Carolina Medical Journal 64(6): 285-286
Rogoff, E.G.; Guirguis, H.S.; Lipton, R.A.; Seremetis, S.V.; DiMichele, D.M.; Agnew, G.M.; Karpatkin, M.; Barish, R.J.; Jones, R.L.; Bianco, C.; Knothe, B.D.; Lee, M-Soo. 2002: The upward spiral of drug costs: a time series analysis of drugs used in the treatment of hemophilia Thrombosis and Haemostasis 88(4): 545-553
Dasgupta, K.; Di Cesar, D.; Ghosn, J.; Rajan, R.; Mahmud, S.; Rahme, E. 2006: Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence Cancer Journal 12(2): 130-135
Schmidt, K. 1996: The elderly cardiovascular patient in general practice. Health care costs--drugs--economic feasibility Fortschritte der Medizin 114(7): 43-44
Dammacco, F.; Iodice, G.; Romagno, D.; Campobasso, N. 1985: Immunological deficiency syndromes, immunosuppression by drugs and occurrence of neoplasms: a casual association? La Ricerca in Clinica e in Laboratorio 15 Suppl. 2: 11-23
Tamir, O.; Friedman, N.; Furman-Assaf, S.; Marom, E.; Arieli, M.; Shemer, J. 2010: Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats Harefuah 149(7): 466-469; 479
Hensley, S. 1999: Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs Modern Healthcare 29(34): 30-34